Expert panel provides framework for incorporating decisiondx-scc results into clinical decision making for cutaneous squamous cell carcinoma patients with one or more risk factors

Friendswood, texas--(business wire)---- $cstl #castlebiosciences--castle today announced a publication describing the findings of a squamous cell carcinoma (scc) gene expression profiling (gep) expert panel.

CSTL Ratings Summary

CSTL Quant Ranking